Ponazuril

Ponazuril, sold by the Bayer Corporation under the trade name Marquis, is a drug currently approved for the treatment of equine protozoal myeloencephalitis in horses, caused by Sarcocystis neurona. Its therapeutic use is listed as antiparasitics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Marquis and Toltrazuril sulfone. Its PubChem CID is 3050408.

CAS No 69004-04-2
Molecular Formula C18H14F3N3O6S
Molecular Weight 457.4 g/mol
Synonyms 1-methyl-3-[3-methyl-4-[4-(trifluoromethylsulfonyl)phenoxy]phenyl]-1,3,5-triazinane-2,4,6-trione

Frequently Asked Questions